Cite
Viallard JF, Agape P, Barlogis V, et al. Treatment with Hizentra in patients with primary and secondary immunodeficiencies: a real-life, non-interventional trial. BMC Immunol. 2016;17(1):34doi: 10.1186/s12865-016-0169-5.
Viallard, J. F., Agape, P., Barlogis, V., Cozon, G., Faure, C., Fouyssac, F., Gaud, C., Gourin, M. P., Hamidou, M., Hoarau, C., Husseini, F., Ojeda-Uribe, M., Pavic, M., Pellier, I., Perlat, A., Schleinitz, N., & Slama, B. (2016). Treatment with Hizentra in patients with primary and secondary immunodeficiencies: a real-life, non-interventional trial. BMC immunology, 17(1), 34. https://doi.org/10.1186/s12865-016-0169-5
Viallard, J F, et al. "Treatment with Hizentra in patients with primary and secondary immunodeficiencies: a real-life, non-interventional trial." BMC immunology vol. 17,1 (2016): 34. doi: https://doi.org/10.1186/s12865-016-0169-5
Viallard JF, Agape P, Barlogis V, Cozon G, Faure C, Fouyssac F, Gaud C, Gourin MP, Hamidou M, Hoarau C, Husseini F, Ojeda-Uribe M, Pavic M, Pellier I, Perlat A, Schleinitz N, Slama B. Treatment with Hizentra in patients with primary and secondary immunodeficiencies: a real-life, non-interventional trial. BMC Immunol. 2016 Sep 29;17(1):34. doi: 10.1186/s12865-016-0169-5. PMID: 27687879; PMCID: PMC5041334.
Copy
Download .nbib